Moving Forward

Moving Forward

Identifying the business/technology issues and solutions for making clinical genomics standard of care – with a call to action

Call to Action #7 – Genomics AI Coalition

Call to Action #7 – Genomics AI Coalition Are healthcare providers and patients ready for AI-based applications for clinical genomics? Let’s create the Genomics AI Coalition (GACT) to purposefully move this forward. GACT goals and activities What are the benefits and challenges of implementing AI-based applications in clinical genomics, and how can they be addressed? […]

Call to Action #6 – Genetic-based care requires care coordination

Call to Action #6 – Genetics-based care requires care coordination Does your local healthcare system on its website clearly list all the genetic and genomic services they provide and how to access them? Questions to Ask As we approach the healthcare systems about this question, what questions should we present to their digital marketing team […]

Call to Action #5 – Adopting one ID for every uniquely offered genetic test

Call to Action #5 – Adopting one ID for every uniquely offered genetic test The Genetic Testing Unit (GTU) is a five-digit alphanumeric character sequence for every uniquely marketed test, even after the test is no longer available. The industry should adopt this coding system as a standard today – so we can move forward. […]

Call to Action #4 – Technology companies building advanced genomic capabilities

Call to Action #4 – Technology companies building advanced genomic capabilities Tech products should clearly show their genomic capabilities and advance their integration of genomic data.   Questions to Ask As we approach the electronic heath record (EHR) vendors, what questions should we ask about their products capabilities that support the implementation of clinical genomics? […]

Call to Action #3 – Insurance company coverage information

Call to Action #3 – Insurance company coverage information Genetic testing costs have decreased substantially, which should eliminate payers having different policies for coverage and reimbursement. With genetic testing the third most common treatment for prior authorization, we need to streamline this process.   Questions to Ask As we approach the heath insurance payers, what […]

Call to Action #2 – Medical specialty groups computable guidelines

Call to Action #2 – Medical specialty groups computable guidelines Medical specialty associations have scientifically developed clear guidelines for the use of clinical genomics in patient care. Now they need to drive requirements so that EHR systems support the computability of those guidelines.   Questions to Ask As we approach the various medical specialty groups, […]

Call to Action #1 – Health system communications on genetic services

Call to Action #1 – Health system communications on the genetic services they provide A major step in making clinical genomics standard of care is for healthcare systems to clearly explain on their website what genetic and genomic services they provide, and guide the patient on how to access them. Questions to Ask As we […]